AI assistant
Sending…
CONMED Corp — Director's Dealing 2023
May 3, 2023
31971_dirs_2023-05-02_55a83727-32fa-4fff-8a81-760637eb7436.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CONMED Corp (CNMD)
CIK: 0000816956
Period of Report: 2023-04-28
Reporting Person: Cohen Heather L (EVP & Chief HR & Legal Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-04-28 | Common Stock | M | 5000 | $32.93 | Acquired | 31997 | Direct |
| 2023-04-28 | Common Stock | F | 2643 | — | Disposed | 29354 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-04-28 | Sars (Stock Appreciation Rights) | $32.93 | M | 5000 | Disposed | 2023-06-01 | Common Stock (5000) | Direct |
Footnotes
F1: The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.
More from CONMED Corp
Regulatory Filings
2026
May 20
Interim / Quarterly Report
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Regulatory Filings
2026
Apr 29
Major Shareholding Notification
2026
Apr 29
Annual Report
2026
Apr 7
Proxy Solicitation & Information Statement
2026
Apr 7
Proxy Solicitation & Information Statement
2026
Apr 7
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 18